FDA Inspection 1102319 — TAIHO ONCOLOGY INC
The FDA completed an inspection of TAIHO ONCOLOGY INC on September 5, 2019 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 5, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Princeton, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)